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Abstract: Aging is characterized by a progressive decline of skeletal muscle (SM) mass and strength 
which may lead to sarcopenia in older persons. To date, a limited number of studies have been 
performed in the old SM looking at the whole, complex network of the extracellular matrix (i.e., 
matrisome) and its aging-associated changes. In this study, skeletal muscle proteins were isolated 
from whole gastrocnemius muscles of adult (12 mo.) and old (24 mo.) mice using three sequential 
extractions, each one analyzed by liquid chromatography with tandem mass spectrometry. Muscle 
sections were investigated using fluorescence- and transmission electron microscopy. This study 
provided the first characterization of the matrisome in the old SM demonstrating several statisti-
cally significantly increased matrisome proteins in the old vs. adult SM. Several proteomic findings 
were confirmed and expanded by morphological data. The current findings shed new light on the 
mutually cooperative interplay between cells and the extracellular environment in the aging SM. 
These data open the door for a better understanding of the mechanisms modulating myocellular 
behavior in aging (e.g., by altering mechano-sensing stimuli as well as signaling pathways) and 
their contribution to age-dependent muscle dysfunction. 
Keywords: aging; extracellular matrix; proteomics; ultrastructure; immunohistochemistry; sarcope-
nia 
1. Introduction
Skeletal muscle (SM) is necessary for locomotion, but it also plays important roles in 
several physiological processes such as bone homeostasis, thermogenesis, and metabo-
lism of amino acids, glucose, and lipids [1,2]. The progressive loss of muscle strength and 
mass, alterations in tissue composition, and increasing denervation can lead to the devel-
opment of sarcopenia, a pathological condition which generally occurs in aging but can 
also occur at a young age [3,4]. Sarcopenia contributes to a lower quality of life since, for 
example, the risk of falls with consequent fractures and loss of independence increases 
and may contribute to the development of type II diabetes and of metabolic syndrome [5]. 
Over the past decades, many studies have shown that sarcopenia is a multifactorial 
process [6] involving, among other factors: (i) reduction in the size and the number of 
myofibers [7]; (ii) satellite cell (SC) exhaustion and altered immune and muscle cell cross-
talk (necessary for muscle proliferative and regenerative capacity) [8]; (iii) mitochondria 
dysfunction causing inefficient energy production [9]; (iv) alterations in insulin-like 
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growth factor 1, Notch, and Wnt/beta-catenin signaling pathways [3]; (v) increase of oxi-
dative stress [10]; and (vi) dysregulation of protein synthesis and degradation [11]. 
The extracellular matrix (ECM) is composed of different groups of macromolecules 
such as collagens, non-collagenous glycoproteins (e.g., laminin, tenascin, and fibronectin), 
glycosaminoglycans (e.g., heparan sulfate), and proteoglycans (e.g., biglycan and lumi-
can) [12]. These macromolecules bind to each other and to cells through integrins, sarco-
glycan complex, and dystroglycan to form an intricate network sending biochemical sig-
nals to myofibres. ECM regulates several cell functions (e.g., growth, differentiation, and 
migration) [13] and represents the structural and functional support for muscle fibers, 
vessels, and nerves, playing a role in the transmission of contractile forces [14], as well as 
muscle development [15], growth, and repair [16]. ECM is affected by the aging process 
in terms of turnover and ratio of specific components, the balance between synthesis and 
degradation of components, modifications in cellular behavior through altered cell-matrix 
interactions, and changes in mechano-sensing pathways. In age-dependent sarcopenia, 
changes in ECM architecture and composition and fibrosis [17] are believed to reduce the 
regenerative capacity of SM and to negatively influence the proliferation and differentia-
tion capability of SC [12,18–20]. The ECM remodeling in sarcopenia has also been linked 
to mitochondrial deterioration [9,19]. However, until now, a limited number of investiga-
tions have been performed in the aging SM looking at the matrisome as the whole complex 
network of ECM molecules. 
In recent years, thanks to the development of mass spectrometry (MS)-based high-
throughput proteomic techniques, large-scale protein characterization is less challenging. 
Proteomic approaches have been successfully applied to SM in different experimental 
models [21–24]. However, to date, there is little information available on ECM proteins of 
SM [25] and their aging-associated changes. 
The identification and quantification of ECM components and their interactions are 
essential steps to understand the role of the matrisome in sarcopenia. In this context, we 
decided to investigate the SM ECM in old compared to adult mice. We are aware that it 
would be of interest to analyze life-long changes, and thus also include muscles from 
young animals. However, it has to be underlined that most changes in muscle protein 
expression are known to take place after middle age [24]. 
The morphology of old SM has been already characterized in previous work from 
our laboratory highlighting several typical features of the sarcopenic condition. A signif-
icantly smaller myofiber cross-sectional area was observed in the SM of old mice [26,27]. 
Although the general cytological organization of the old myofiber was not grossly altered, 
morphometrical studies highlighted several age-related modifications (e.g., accumulation 
of larger inter-myofibrillar and sub-sarcolemmal mitochondria, larger myonuclei with in-
creased condensed chromatin, impairment of RNA maturation/export pathways, de-
creased amount of active satellite cells) [28–30]. In this work, the gastrocnemius muscle 
was selected for analysis since it is prevalently composed of fast-twitch fibers [27], which 
are especially affected by atrophy during aging. 
Therefore, to shed light on age-related changes in the matrisome of the gastrocnem-
ius muscle, we combined a proteomic approach (i.e., liquid chromatography (LC)-MS/MS 
and bioinformatic analyses) with morphological and morphometrical evaluations of sec-
tions observed by fluorescence and transmission electron microscopy. 
Results provided novel characterization of the aging matrisome. Higher amounts of 
several ECM proteins in old vs. adult muscle were demonstrated, thereby shedding new 
light on the mutually cooperative interplay between cells and the extracellular environ-
ment. This study opens the door to a better understanding of the mechanisms modulating 
myocellular behavior (e.g., alteration of mechano-sensing stimuli and/or signaling path-
ways). 
  




2.1. Identification of Proteins in the Gastrocnemius Muscle 
In this study, samples of gastrocnemius muscle were subjected to three sequential 
extractions, each one being analyzed by LC-MS/MS. In particular, phosphate buffer saline 
(PBS) was used to solubilize hydrophilic proteins (PBS extract), and then the insoluble 
part was treated with a combination of urea (U) and thiourea (T) to extract hydrophobic 
molecules such as membrane proteins, myofibrillar, and part of ECM proteins (U/T ex-
tract) [31]. Finally, the remaining insoluble fraction was treated with guanidine-HCl 
(GuHCl extract), one of the most efficient chaotropic agents which is known to extract 
poorly soluble, heavily cross-linked proteins, and proteoglycans. This approach has been 
reported to improve protein extraction from ECM-rich tissues (e.g., cartilage, tendon) 
[32,33] (Figure 1a). 
This strategy allowed us to identify, with at least 1 unique peptide, 2134 different 
proteins (Table S1) of which 474 were identified in all 3 extracts, while 588, 364, and 140 
proteins were detected in the PBS, U/T, and GuHCl extracts, respectively (Figure 1b). 
 
Figure 1. (a) Sequential protein extraction from gastrocnemius muscle. (b) The Venn diagram shows 
the number of proteins identified in each extract. 
To reveal the ECM composition of the gastrocnemius muscle, the 2134 identified pro-
teins were further analyzed by interrogating the MatrisomeDB, a database that includes 
all structural ECM components and proteins that may directly or indirectly interact with 
the ECM [34]. The matrisome is constituted by a “core matrisome”, comprising collagens, 
proteoglycans, and glycoproteins, and by “matrisome-associated proteins”, which in-
clude secreted factors, ECM-affiliated proteins, and ECM regulators [35]. As shown in Ta-
ble 1, 124 proteins were found to be part of ECM; in particular, 14, 38, and 10 proteins 
belong to the collagen, glycoprotein, and proteoglycan category, respectively. Sixty-two 
proteins constituted the “matrisome-associated proteins” (i.e., 15, 37, and 10 proteins rep-
resenting ECM-affiliated proteins, ECM regulators, and secreted factors, respectively). 
43% (54/124) of proteins were found only after U/T and GuHCl extract of which 28 poly-
peptides were identified in both extracts (i.e., U/T and GuHCl) and 13 only with U/T or 
with GuHCl buffer. 
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Table 1. ECM and ECM-associated components from the gastrocnemius muscle categorized according to MatrisomeDB. 
Protein Symbol Protein Name Protein Symbol Protein Name 
MATRISOME DIVISION: CORE MATRISOME  
Category: collagen    
CO1A1 Collagen alpha-1(I) chain CO6A1 Collagen alpha-1(VI) chain 
CO1A2 Collagen alpha-2(I) chain CO6A2 Collagen alpha-2(VI) chain 
CO3A1 Collagen alpha-1(III) chain CO6A6 Collagen alpha-6(VI) chain 
CO4A1 Collagen alpha-1(IV) chain COBA1 Collagen alpha-1(XI) chain 
CO4A2 Collagen alpha-2(IV) chain COEA1 Collagen alpha-1(XIV) chain 
CO5A1 Collagen alpha-1(V) chain COFA1 Collagen alpha-1(XV) chain 
CO5A2 Collagen alpha-2(V) chain COIA1 Collagen alpha-1(XVIII) chain 
Category: ECM-glycoproteins   
ADIPO Adiponectin LAMB1 Laminin subunit beta-1 
AGRIN Agrin LAMB2 Laminin subunit beta-2 
BGH3 
Transforming growth factor-beta-in-
duced protein ig-h3 
LAMC1 Laminin subunit gamma-1 
CILP1 Cartilage intermediate layer protein 1 MFAP2 Microfibrillar-associated protein 2 
CILP2 Cartilage intermediate layer protein 2 MFAP4 Microfibril-associated glycoprotein 4 
COMP Cartilage oligomeric matrix protein MFAP5 Microfibrillar-associated protein 5 
CREL1 
Cysteine-rich with EGF-like domain 
protein 1 
MFGM Lactadherin 
DERM Dermatopontin NID1 Nidogen-1 
FBN1 Fibrillin-1 NID2 Nidogen-2 
FBN2 Fibrillin-2 POSTN Periostin 
FIBA Fibrinogen alpha chain SLIT2 Slit homolog 2 protein 
FIBB Fibrinogen beta chain SRPX Sushi-repeat-containing protein SRPX 
FIBG Fibrinogen gamma chain SSPO SCO-spondin 




TINAL Tubulointerstitial nephritis antigen-like 
LAMA2 Laminin subunit alpha-2 TSP1 Thrombospondin-1 
LAMA3 Laminin subunit alpha-3 TSP4 Thrombospondin-4 
LAMA4 Laminin subunit alpha-4 VMA5A 
von Willebrand factor A domain-containing pro-
tein 5A 
LAMA5 Laminin subunit alpha-5 VWA1 
von Willebrand factor A domain-containing pro-
tein 1 
Category: Proteoglycans   
ASPN Asporin PGBM 
Basement membrane-specific heparan sulfate pro-
teoglycan core protein 
CHADL Chondroadherin-like protein PGS1 Biglycan 
FMOD Fibromodulin PGS2 Decorin 
LUM Lumican PRELP Prolargin 
MIME Mimecan PRG2 Bone marrow proteoglycan 
MATRISOME DIVISION: MATRISOME-ASSOCIATED PROTEINS 
Category: ECM affiliated proteins  
ANXA1 Annexin A1 GPC1 Glypican-1 
ANXA2 Annexin A2 HEMO Hemopexin 
ANXA3 Annexin A3 LEG1 Galectin-1 
ANXA4 Annexin A4 LEGL Galectin-related protein 
ANXA5 Annexin A5 LMAN1 Protein ERGIC-53 
ANXA6 Annexin A6 PLXA4 Plexin-A4 
ANXA7 Annexin A7 PLXB3 Plexin-B3 
ANX11 Annexin A11   
Category: ECM regulators   
A1AT1 Alpha-1-antitrypsin 1-1 ITIH1 Inter-alpha-trypsin inhibitor heavy chain H1 
A1AT2 Alpha-1-antitrypsin 1-2 ITIH2 Inter-alpha-trypsin inhibitor heavy chain H2 
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A1AT3 Alpha-1-antitrypsin 1-3 ITIH3 Inter-alpha-trypsin inhibitor heavy chain H3 
A1AT4 Alpha-1-antitrypsin 1-4 ITIH4 Inter alpha-trypsin inhibitor, heavy chain 4 
A2AP Alpha-2-antiplasmin ITIH5 Inter-alpha-trypsin inhibitor heavy chain H5 
AMBP Protein AMBP KNG1 Kininogen-1 
ANGT Angiotensinogen MMP17 Matrix metalloproteinase-17 
ANT3 Antithrombin-III PEDF Pigment epithelium-derived factor 
CATB Cathepsin B PLMN Plasminogen 
CATD Cathepsin D PZP Pregnancy zone protein 
CBG Corticosteroid-binding globulin SERPH Serpin H1 
CPN2 Carboxypeptidase N subunit 2 SPA3K Serine protease inhibitor A3K 
CYTB Cystatin-B SPA3M Serine protease inhibitor A3M 
FA12 Coagulation factor XII SPA3N Serine protease inhibitor A3N 
HEP2 Heparin cofactor 2 SPI2 Serpin I2 
HRG Histidine-rich glycoprotein SULF2 Extracellular sulfatase Sulf-2 
HYAL2 Hyaluronidase-2 TGM2 Protein-glutamine gamma-glutamyltransferase 2 
IC1 Plasma protease C1 inhibitor THRB Prothrombin 
ILEUA Leukocyte elastase inhibitor A   
Category: secreted factors   
ANGL7 Angiopoietin-related protein 7 S10A1 Protein S100-A1 
FILA2 Filaggrin-2 S10A4 Protein S100-A4 
HGFA Hepatocyte growth factor activator S10A6 Protein S100-A6 
INHBA Inhibin beta A chain S10AA Protein S100-A10 
MEG11 
Multiple epidermal growth factor-like 
domains protein 11 
WN10A Protein Wnt-10a 
2.2. Matrisome Quantification: Old SM vs. Adult SM. 
To compare the relative abundance of matrisome proteins between adult and old 
muscle, we performed a label-free quantification, which was based on the measure of pre-
cursor ion intensities. Even though protein quantification can be performed on proteins 
identified with a single peptide [36], we preferred to quantify matrisome proteins which 
were identified with at least two peptides (i.e., 91/124 proteins) (for more details see ma-
terial and methods) (Table S2), as only one peptide can be incorrectly quantified across 
LC-MS runs [37]. 
Table 2 lists only proteins that changed significantly between old and adult muscles 
(i.e., 18, 21, and 3 in PBS, U/T, and GuHCl extracts, respectively). Except for AnnexinA6, 
whose amount was significantly lower in aging SM, all other listed proteins were statisti-
cally significantly more abundant in old vs. adult SM. No statistically significant changes 
were found for proteins belonging to the category of secreted factors. 
Table 2. List of matrisome proteins whose amount statistically significantly changed in old vs. adult gastrocnemius mus-







Log2 Fold Change 
p-Value 
ECM regulators 
A1AT2 Alpha-1-antitrypsin 1-2 0.69 0.006 
A2AP Alpha-2-antiplasmin 1.04 0.038 
CATD Cathepsin D  0.58 0.001 
CBG Corticosteroid-binding globulin 1.82 0.049 
ILEUA Leukocyte elastase inhibitor A  1.11 0.008 
ITIH2 Inter-alpha-trypsin inhibitor heavy chain H2  2.00 0.038 
ITIH4 Inter alpha-trypsin inhibitor, heavy chain 4  1.42 0.018 
KNG1 Kininogen-1  0.97 0.043 
PEDF Pigment epithelium-derived factor  1.11 0.040 
PZP Pregnancy zone protein  0.86 0.012 
SPA3N Serine protease inhibitor A3N  1.77 0.028 




FIBA Fibrinogen alpha chain  1.19 0.001 
FIBB Fibrinogen beta chain  1.19 0.001 
FIBG Fibrinogen gamma chain 1.14 0.001 
TSP4 Thrombospondin-4 1.44 0.000 
VMA5A 
von Willebrand factor A domain-containing pro-
tein 5A  
0.81 0.000 
Proteoglycans 
ASPN Asporin  0.53 0.004 
LUM Lumican  0.48 0.030 
PRELP Prolargin  0.37 0.001 
ECM affiliated proteins 
ANXA4 Annexin A4  0.63 0.002 
ANXA5 Annexin A5  0.51 0.009 
ANXA6 Annexin A6  −0.39 0.008 
ANX11 Annexin A11  0.28 0.021 
HEMO Hemopexin 0.74 0.018 
U/T Extract 
Collagen 
CO4A1 Collagen alpha-1(IV) chain 1.30 0.016 
CO6A1 Collagen alpha-1(VI) chain 0.61 0.000 
CO6A2 Collagen alpha-2(VI) chain 0.59 0.001 
ECM regulators 
A1AT2 Alpha-1-antitrypsin 1-2  0.87 0.022 
CATD Cathepsin D 1.04 0.000 
TGM2 Protein-glutamine gamma-glutamyltransferase 2 0.80 0.013 
ECM glycoproteins 
BGH3 
Transforming growth factor-beta-induced protein 
ig-h3  
0.78 0.016 
CILP1 Cartilage intermediate layer protein 1  1.47 0.000 
DERM Dermatopontin  0.51 0.004 
FINC Fibronectin  1.35 0.036 
LAMA2 Laminin subunit alpha-2  0.45 0.000 
LAMA5 Laminin subunit alpha-5  0.79 0.002 
LAMB1 Laminin subunit beta-1  0.47 0.010 
LAMB2 Laminin subunit beta-2  0.53 0.000 
LAMC1 Laminin subunit gamma-1  0.56 0.000 
NID1 Nidogen-1  0.54 0.000 
NID2 Nidogen-2  1.09 0.000 
POSTN Periostin  1.28 0.003 
TENA Tenascin  2.55 0.022 
TSP4 Thrombospondin-4 1.34 0.048 
Proteoglycans 
ASPN Asporin  0.79 0.008 
FMOD Fibromodulin  0.73 0.005 
LUM Lumican  0.81 0.001 
MIME Mimecan  0.54 0.008 
PGS1 Biglycan  1.05 0.002 
PRELP Prolargin  0.87 0.007 
ECM affiliated proteins 
ANXA2 Annexin A2  0.42 0.005 
ANXA5 Annexin A5 2.28 0.002 
HEMO Hemopexin 1.59 0.007 
ANX11 Annexin A11  0.90 0.000 
LEG1 Galectin-1  1.19 0.021 
GuHCl Extract 
Collagens COFA1 Collagen alpha-1(XV) chain  0.67 0.019 
ECM glycoproteins LAMA5 Laminin subunit alpha-5  0.81 0.006 
ECM affiliated proteins ANXA2 Annexin A2  0.67 0.046 
2.3. Ultrastructural Morphology and Morphometrical Evaluation 
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To correlate matrisome changes with structural features, gastrocnemius muscles 
from adult and old mice were collected and processed for morphological and morpho-
metrical analyses using transmission electron microscopy. 
The general organization of myofibers in adult and old mice is shown in Figure 2a,c,  
confirming previous works from our laboratory [28,29]. In both age groups, the endo-
mysium was comprised of a network of collagen fibrils connected to the basement mem-
brane, which was covering the surface of skeletal muscle cells an electrodense sheath (Fig-
ure 2b,d). 
 
Figure 2. Ultrastructural images of the endomysium in adult (a,b) and old (c,d) gastrocnemius mus-
cle. *, endomysium; arrowhead, basement membrane. Bars: 500 nm. The endomysium and basement 
membrane thickness are reported in panels (e) and (f), respectively. * p < 0.001. 
Morphometrical evaluation of the endomysium thickness performed measuring the 
distance between the sarcolemma of two adjacent longitudinally sectioned myofibers, re-
vealed no statistically significant difference in adult vs. old mice (0.685 ± 0.041 and 0.611 
± 0.048; p = 0.25, Figure 2e). Instead, the thickness of the basement membrane was signifi-
cantly higher in old vs. adult mice (29.72 ± 0.61 nm vs. 41.88 ± 1.07 nm; p < 0.001; Figure 
2f), in agreement with the increased amount of basement membrane’s components iden-
tified by proteomic and immunofluorescence analyses (vide infra). 
The extracellular matrix of the perimysium was organized in collagen bundles of dif-
ferent sizes and orientations (Figure 3a,c). In comparison with adult animals, old mice 
perimysium presented statistically significantly larger collagen bundles (759.16 ± 52.05 nm 
vs. 1461.66 ± 75.2 nm; p < 0.001; Figure 3e), which were also more linear (linearity index: 
1.05 ± 0.01 vs. 1.03 ± 0.03; p = 0.03; Figure 3f). Morphometrical evaluation of the collagen 
fibrils of the perimysium (Figure 3b,d) revealed no statistically significant difference in 
size in adult vs. old mice (21.0 ± 0.65 nm and 21.4 ± 0.50 nm; p = 0.62, Figure 3g). The 
distance between collagen fibrils was statistically significantly higher in old vs. adult mice 
(9.26 ± 0.92 nm and 5.84.45 ± 0.56 nm; p = 0.006; Figure 3h). 




Figure 3. Ultrastructural images (a–d) of the perimysium of adult (a,b) and old (c,d) gastrocnemius muscle. CB, collagen 
bundle. a and c, bars: 1 µm; b and d, bars: 100 nm. Morphometric analysis of collagen bundles and collagen fibrils features 
are reported in the histograms (e–h). X/Y, ratio between the real length of the collagen bundle profile and the correspond-
ing linear length. * p < 0.05. 
2.4. Evaluation of ECM Components by Immunofluorescence 
Immunofluorescence was performed on gastrocnemius cryosections from adult and 
old mice using specific antibodies directed against the ECM components collagen type VI 
(as representative interconnection factor between basement membrane and fibrillar colla-
gen) and laminin (as constituent of the basement membrane) (Figure 4). Differences in the 
immunolabelling distribution were present in the two age groups. In particular, the im-
munostaining for both collagen type VI (Figure 4a,d) and laminin (Figure 4b,e) appeared 
more abundant in old vs. adult mice. Qualitative observations were confirmed by quanti-
fying the area covered by fluorescence-positive pixels through a MATLAB routine. Both 
type VI collagen (0.1368 ± 0.0090 vs. 0.0621 ± 0.0097, p < 0.001, Figure 4g) and laminin 
(0.1728 ± 0.0084 vs. 0.0707 ± 0.0071; p < 0.001, Figure 4h) were statistically significantly 
increased in old SM. 




Figure 4. Type VI collagen (a,d) and laminin (b,e) immunolabelling of gastrocnemius cryosections in adult (a–c) and old 
(d–f) mice. DNA was counterstained with Hoechst (c,f). Bar: 50 µm. Panels (g) and (h), respectively, show quantification 
of the immunolabelling for type VI collagen and laminin expressed as % of total area). * p < 0.001. 
Immunolabelling for type I collagen (as representative of fibrillar collagens) (Figure 
5) revealed qualitatively different staining in the two groups of mice. Quantification of the 
area covered by fluorescence-positive pixels for type I collagen showed no statistically 
significant difference in the two age groups (adult, 0.0359 ± 0.0086; old, 0.0514 ± 0.0113; p 
= 0.275). 
 
Figure 5. Type I collagen (a,c) immunolabelling of gastrocnemius cryosections of adult (a,b) and old 
(c,d) mice. DNA was counterstained with Hoechst (b,d). Bar: 10 µm. 
3. Discussion 
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In aging, SM can suffer from low muscle strength and low muscle quality and quan-
tity which may lead to sarcopenia [4]. 
To characterize and to understand the processes of sarcopenia, many studies using 
diverse techniques (e.g., computerized tomography, magnetic resonance imaging, elec-
tron microscopy, transcriptomic analyses) have mainly focused on changes of the SM me-
chanical properties and/or alterations of myofibers and SC [38,39]. Moreover, thanks to 
the development of MS-based proteomics, the intracellular proteins of the aged SM were 
investigated [40,41]. However, little emphasis has been given to the matrisome, despite 
growing evidence indicating the ECM as an essential player in SM function. In fact, the 
matrisome not only constitutes the architectural scaffold for myofibers [42,43], but it is 
also a reservoir for signaling molecules (e.g., cytokines, chemokines, and growth factors) 
responding to different stimuli and to stress to maintain cellular homeostasis. Actually, 
the matrisome is a dynamic compartment mediating outside-in signaling and vice-versa 
between cells and the surrounding environment [44]. Therefore, in this study, we focused 
on the matrisome of the whole gastrocnemius muscle by applying a sequential extraction 
procedure in combination with LC-MS/MS analysis to reveal changes occurring with ag-
ing. It is worth remembering that, to date, there is no protocol and/or proteomic technique 
capable of detecting the entire complexity of the proteome, so our strategy was a compro-
mise between sensitivity and quantitative accuracy. We were able to identify many ECM 
components, some of them (e.g., collagens, proteoglycans, glycoproteins) being only ex-
tracted after strong solubilization conditions such as urea/thiourea and/or guanidinium-
HCl. 
Our proteomic data demonstrated that changes in matrisome proteins mostly con-
sisted of increased protein abundance in old vs. adult skeletal muscles. 
3.1. Alteration of Core Matrisome in Aged vs. Adult Mice 
Among the “core matrisome” collagen category, we revealed a significant age-de-
pendent increase of collagen type IV and VI, which was confirmed by quantitative immu-
nofluorescence. 
Collagen type VI is present in the epimysial, perimysial, and endomysial interstitium 
playing a key role in maintaining the SM functional integrity as it represents, together 
with fibronectin and proteoglycans, the major constituent of the “niche”, where the bal-
ance between differentiation, self-renewal, and maintenance of muscle regeneration ca-
pacity takes place [20,45]. Collagen type VI is typically organized as a heterotrimer of α1, 
α2, and α3 chains, but, recently, three new α chains have been described [46]. Since the α 
chains have a different length and we have demonstrated an increased abundance of only 
α1 and α2 chain, it could be suggested that an altered ratio among the various collagen 
type VI chains affects the stability and the supramolecular assembly of the beaded fila-
ments, altering the role of type VI collagen as an anchoring component of basement mem-
branes through the interactions with collagen type IV, biglycan, fibronectin, sarcolemma 
integrins, and cell surface proteoglycans [46]. Interestingly, thickening of the immunoflu-
orescence staining area for type VI collagen occurred in the gastrocnemius of old mice, 
further supporting an age-associated alteration of the organization of the anchoring sys-
tem. 
Collagen type IV is a structural molecule of the basement membrane, and its concen-
tration appeared to increase in old muscle, in agreement with previous observations, [47] 
although with differences depending on muscle type. Collagen type IV accumulation has 
been shown to drive out SC from their niche, thus potentially contributing to the satellite 
cell reduction observed in aging [29,48,49]. 
It is to be noted that, despite the increased amount of type IV and VI collagen con-
tributing to the increased thickness of basement membranes, the endomysium thickness 
was not changed in adult and old mice. Accordingly, no overall age-associated hypertro-
phy of the ECM component was previously demonstrated in mouse skeletal muscle [50]. 
Moreover, in the present study, the amount of fibrillar collagens (i.e., collagen type I, III, 
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and V) in the mouse gastrocnemius muscle did not change with aging. Data reported in 
the literature are very heterogeneous [51–54], but the loss of muscle performance has been 
generally related to fibrosis, although, by transcriptomic analysis, collagen genes (i.e., col-
lagen type I and III) appeared significantly downregulated in aging [55]. The discrepancy 
among different studies may be related to the type or specific portion of muscles analyzed, 
to sample preparation, and/or to methods applied to quantify collagen (e.g., hydroxypro-
line measured by HPLC, collagen staining, transcriptomic analysis, proteomic analysis). 
Moreover, collagen accumulation may be due to excessive production, the altered balance 
between degradative enzymes and their inhibitors, a combination of the altered ratio be-
tween synthesis and degradation, or may be the result of post-translational modification 
and glycation crosslinking, thus increasing insolubility and lowering the ability of prote-
olytic enzymes to provide an efficient turnover [56]. 
Even if we did not observe statistically significant differences in the amount of colla-
gen type I by LC-MS/MS and immunofluorescence, the fibrillar collagen in the perimys-
ium (predominantly collagen type I) [57] of old animals showed a more linear and loosely 
organized distribution with an increased distance between collagen fibrils that may likely 
allow the interposition of other ECM constituents. Interestingly, a statistically significant 
decrease in collagen fiber “tortuosity” [19] and the accumulation of extensively cross-
linked collagen together with the reduced size of most myofibers [26,27] have been advo-
cated as a cause of increased muscle stiffness [49,50]. Muscle stiffness has been recently 
reported to increase, together with ECM amount, in human skeletal muscle of aged vs. 
young subjects [58]. Accordingly, muscle stiffness is considered a typical hallmark of mus-
cle aging, [50–52,59] as well as the decreased compliance of myofibers in response to ten-
sile loading [19]. 
 
Other components of the matrisome are glycoproteins such as laminin, fibronectin, 
and nidogen, which were detected in higher amounts in old compared to adult SM. Since 
these glycoproteins act as a bridge between collagen type IV and the sarcolemma of mus-
cle fibers [60], their increased amount is consistent with the higher thickness of the base-
ment membrane observed in old animals. Moreover, the increase of laminin during aging 
can modify the ability of the basement membrane to store and release growth factors and 
other bioactive molecules required to form the SC niche [61] and to activate SC, thus sup-
porting the previous finding of SC reduced activation potential in old mice [29]. In aged 
muscle, the shift from functional myofiber repair towards increased extracellular matrix 
deposition is also associated with changes in the micro-environment and the interactions 
between ECM glycoproteins as fibronectin, periostin, and tenascin. Interestingly, all of 
these molecules appeared to increase in the old gastrocnemius muscle. 
Fibronectin, for instance, is one of the most widespread glycoproteins of the ECM, 
playing a role in various processes such as cellular adhesion, spreading and migration, as 
well as cellular development and differentiation. The increased abundance of fibronectin 
in old gastrocnemius is in agreement with very recent data demonstrating an association 
between high fibronectin levels in the aged gastrocnemius muscle, the reduced muscular 
strength, and myogenic regeneration and differentiation [62]. 
Periostin is a member of the TGF-beta family of proteins with a putative role associ-
ated with pathologic fibrotic events [63]. It is present in the endomysial space and func-
tions upstream and downstream of TGF-beta [64]. Its expression is low in adult tissues, 
but it is strongly induced and secreted after injury or in dystrophic skeletal muscle [65]. 
Tenascin is present in all musculoskeletal regions in which high mechanical forces 
are transmitted, is upregulated in the damage/repair cycle [66] being produced in re-
sponse to degeneration and the release of growth factors as TGF-beta, and was found to 
accumulate in the endomysium predominantly in the vicinity of necrotic and regenerating 
myofibers [67]. As it was also observed in association with atrophy and with age-induced 
atrophy, it may represent a possible cofactor in the etiology of sarcopenia [68,69]. 
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Interestingly, thrombospondin (TSP1) is also an ECM molecule that was observed to 
be markedly increased in the aging SM. It modulates cell function by binding to matrix 
proteins and growth factors altering the properties of ECM and engaging signaling recep-
tors on the cell surface with the activation of latent TGF-beta1. TSP1 promotes aging and 
it is in turn upregulated by age-related factors as ROS, glucose, and hypoxia and nega-
tively affects mitochondria biogenesis and efficiency as well as endothelial cell prolifera-
tion [70,71]. 
TGF-beta signaling and expression may lead to increased collagens’ deposition and 
to the development of an age-dependent fibrotic environment correlated to fibrin/fibrin-
ogen accumulation, thus suggesting a possible involvement of macrophages within a gen-
eralized inflammatory response [72]. These data support the concept that inflammatory 
and coagulation pathways are increasingly active with aging and can contribute to sarco-
penia and frailty [73]. 
 
The matrisome structure and organization are also sustained by the interaction be-
tween proteoglycans (PGs) and collagens [74]. For instance, biglycan and lumican bind to 
collagen regulating collagen fibrillogenesis, collagen fibril thickness, and notably interfi-
brillar spacing, which are important for tissue integrity. Interestingly, in old vs. adult 
mice, collagen bundles were characterized by the increased distance between fibrils in the 
presence of similar fibril size. This necessitates further, more detailed analysis of PGs/col-
lagens interactions in aging skeletal muscle. PGs also bind to different growth factors, 
influencing their bioavailability, cell proliferation, and matrix deposition [75]. In this 
study, we have observed higher levels of some PGs (e.g., lumican, biglycan, and asporin) 
in old compared to adult SM. These results are not consistent with those of a recent study, 
which highlighted a downregulated gene expression of laminin, fibronectin, nidogen, and 
biglycan in aged SM [55]. This discrepancy is not surprising as many studies have already 
demonstrated that transcriptomic data had a low correlation with their corresponding 
proteins [76–78]. For instance, the decoupling of the proteome and transcriptome can be 
due to i) post-transcriptional mechanisms regulating protein abundance; ii) greater stabil-
ity of proteins compared to transcripts; iii) decreased proteolytic activity; and iv) changes 
in protein synthesis rates. 
3.2. Alteration of Matrisome-Associated Proteins in Aged vs. Adult Mice  
Among ECM affiliated proteins, annexins (ANX) can play a critical role in cell mem-
brane repair. The sarcolemma is subjected to severe mechanical stress and continuous 
stretching and the repair machinery is required to preserve and maintain membrane in-
tegrity. ANXA6 is a key factor in the repair machinery, and accumulates at the site of 
sarcolemma injury. This event precedes the activation of ANXA1 and ANXA2. ANXA6 is 
the only protein that we have observed to be significantly reduced in aging muscle. Re-
duction of ANXA6 inhibits the aggregation of ANXA1, ANXA2, and ANXA5, thus nega-
tively affecting the repair process [79]. Moreover, an excess of ANXA2 that leaks from 
injured myofibers can activate muscle-resident fibro-adipogenic precursors that differen-
tiate into adipocytes which gradually lead to muscle degeneration [80]. 
Muscle repair processes are also modulated by myoblasts-matrix interactions 
through interaction between laminin and galectin 1 [81]. Since galectin 1 is upregulated in 
old SM, these data confirm the higher expression that was detected in the signature of the 
age-dependent sarcopenia that is involved in mediating cellular responses to inflamma-
tion and apoptosis [82], in the terminal differentiation of myoblasts and the disruption of 
adhesion of myoblasts to laminin [83]. 
 
The homeostasis of the matrisome is finely controlled by different ECM regulators. 
Both in PBS and U/T extract we revealed an increase of cathepsin D in old compared 
to adult SM. Cathepsin D exhibits its activity in the lysosome, but when the cells break it 
is released in the extracellular space. This molecule has been recently proposed as a 
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sarcopenia biomarker, as its levels were significantly higher in sarcopenic patients than in 
control subjects [84]. 
Similarly, matrix metalloproteases (MMPs), ECM-associated enzymes, play a crucial 
role in regulating the degradation of matrisome molecules [85]. Except for MMP17, which 
did not change in aging, other MMPs or their inhibitors have been not identified in this 
study. This could be due to either their low concentration in our experimental conditions 
or stringent parameters applied in this study or different resolutions of LC-MS/MS, which 
is crucial for identifying scarce proteins. 
By contrast, the inter alpha trypsin inhibitor heavy chain (ITIH4) is increased in aged 
SM. However, despite the name, it does not possess intrinsic trypsin inhibitory activity, is 
upregulated by IL-6, and is involved in the stabilization of the extracellular matrix [86], 
further supporting the occurrence of molecules involved and favoring the progressive ac-
cumulation of ECM in the environment surrounding myofibers. 
Moreover, among ECM regulators, we have observed an increase of PEDF, a mole-
cule that, inducing endothelial cell apoptosis, exerts antiangiogenic properties. Reduction 
of blood vessels may negatively affect nutrient and oxygen availability and therefore mus-
cle metabolism. PEDF is upregulated in the aging muscle and is highly expressed in mes-
enchymal stem cells from old donors [87]. 
4. Materials and Methods 
4.1. Reagents 
All reagents were purchased from Sigma-Aldrich (Merk KGaA, Taufkirchen, Ger-
many) unless otherwise stated. 
4.2. Mice 
Male BALB/c mice aged 12 months (adult, n = 9) and 24 months (old, n = 9) were used 
in this study. The mice, housed in groups of three to four, were maintained under stand-
ard conditions (24 ± 1 °C ambient temperature, 60 ± 15% relative humidity, and 12 h 
light/dark cycle) and fed ad libitum with standard commercial chow. The animals had only 
spontaneous free-moving activity in the cage. 
4.3. Proteomic Analysis 
4.3.1. Preparation of Protein Samples for Proteomic Analysis 
The whole gastrocnemius muscles were quickly removed from three mice for each 
age group and froze for proteomic analysis. Each muscle underwent a three-step sequen-
tial extraction (Figure 1a). Frozen muscle was homogenized on ice in phosphate buffer 
(PBS; 1:10 w/v) using a glass homogenizer to solubilize cellular and hydrophilic proteins. 
Samples were centrifuged at 8000× g for 30 min at 4 °C. After recovering the supernatants 
(PBS extract), the resulting pellets were resuspended in urea-thiourea buffer (1:10 w/v) 
and incubated at 4 °C for 24 h under continuous shaking. After centrifugation at 15,000× 
g for 20 min at 4 °C, the supernatant (U/T extract) was recovered, and the pellet was fur-
thermore homogenized in guanidinium-HCl buffer (pH = 8.5, 1:5 w/v), heated at 100 °C 
for 10 min and collected (GuHCl extract). 
These last steps were provided to maximize the extracellular matrix protein recovery. 
The protein concentration of each fraction was quantified using the Bradford method. 200 
µg of proteins/fraction/muscle were subjected to proteomic analysis. 
For each fraction, a gel-tube digestion was performed as already described [88]. The 
proteins embedded in the gel-tube were reduced by incubation with 10 mM dithioeryth-
ritol/100 mM ammonium bicarbonate for 45 min at 56 °C and then alkylated with 55 mM 
iodoacetamide/100 mM ammonium bicarbonate for 30 min at RT in the dark. Proteins 
were digested overnight at 37 °C in 100 mM ammonium bicarbonate pH 8.0 using se-
quencing grade trypsin at a 1:100 enzyme-to-protein ratio (Promega, Madison, MI, USA). 
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Peptides were extracted from gel-tubes with 100% acetonitrile and dried with a SpeedVac 
(Eppendorf AG, Hamburg, Germany). 
4.3.2. Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) 
Peptides obtained from each fraction were resuspended in water/formic acid solution 
(95:3:2). A UHPLC ultimate 3000 system coupled online to a Q Exactive Hybrid Quadru-
pole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) was 
used, as already described [89] with some modifications. Chromatographic separation of 
peptides took place in a reverse-phase C18 column (100 mm × 2.1 μm ID, 1.9 μm, HyperG 
Thermo Fischer Scientific) and elution was performed using a binary system of solvents. 
Solvent A was 0,1% formic acid and solvent B was pure acetonitrile. A linear binary gra-
dient was applied to eluate the peptides: 0–20% solvent B in solvent A for 240 min and 
further 60 min of 20–40% solvent B in solvent A. The precursor ion detection was done in 
an m/z-range from 400 to 1800 and the acquisition range for fragment ions was m/z from 
200 to 2000. The sample injection flow was 0.5 mL/min, and the column was kept at a 
constant temperature of 30 °C. Data acquisition was controlled by Xcalibur 2.0.7 Software 
(Thermo Fisher Scientific, USA). Six independent experiments (three for adult and three 
for old muscles) were performed and each fraction obtained from each muscle was ana-
lyzed in duplicate. 
4.3.3. Data Processing for Protein Identification and Quantification 
Raw MS/MS data (.raw) were inspected using BatMass (v. 0.3.0). Replicates were 
aligned using FreeStyle (v.1.5) to check the quality of runs. Raw files were further con-
verted by msConvert ProteoWizard (v.3.0.19239) in MGF file using default settings and 
uploaded to MASCOT server (v.2.7.0) for MS/MS Ion Search. The search was performed 
using Uniprot (2018_05) restricted to Mus musculus (Taxonomy ID: 10090) and cRAP da-
tabase to detect most commonly adventitious proteins 
(https://www.thegpm.org/GPM/index.html (accessed on 6 April 2021:)). Parameters for 
identification included: (i) trypsin as an enzyme with 1 as maximum missed cleavage; (ii) 
mass error tolerances for precursor and fragment ions set to 10 ppm and 0.02 Da, respec-
tively; (iii) peptide charge (2+, 3+, 4+); (iv) protein mass no restriction; and (v) carbami-
domethyl cysteine (C) was set as fixed modification while deamidation of asparagine and 
glutamine (NQ), oxidation of methionine (M) and cysteine propionamide (C) were con-
sidered as variable modifications. Only confident peptide identified with a false discovery 
rate ≤ 1 and protein with at least one unique peptide were exported. 
Mascot results (.dat) obtained for each extraction were imported in Skyline-daily 
(v.21.0.9.139) to generate the spectral libraries using the following parameters: 0.95 as 
spectra cut-off score; peptide length of 8-25 amino acids; precursor ion charge 2+, 3+, 4+; 
MS1 filters were set to “use high selectivity extraction” with a resolving power of 60,000 
at 300 m/z; repeated and duplicate peptides were removed. Accordingly, to Skyline “DDA 
peptide search” workflow, raw files (.raw) were imported and matched to spectral librar-
ies to recover precursor ion intensity. Precursor ion intensity is the sum of areas under the 
curve of extracted ion chromatograms (XICs) containing precursor ion isotope peaks (M, 
M+1, M+2) [90]. Fasta files containing proteins with 1% FDR were imported to Skyline to 
maintain and fix FDR. Finally, quantitative analysis was performed on proteins with at 
least two peptides. Indeed, protein inference is mainly based on the unique peptides that 
are not shared by multiple proteins. However, one peptide can be incorrectly quantified 
across LC-MS runs, producing improper quantification. In this perspective, first of all, a 
proteome discovery study was performed releasing a list of proteins identified with at 
least one unique peptide, and secondly, a label-free quantification study was performed 
only on proteins identified with at least two peptides to reduce incorrect quantification 
[37]. 
4.4. Bioinformatic Analysis 
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We interrogated the MatrisomeDB (http://www.pepchem.org/matrisomedb (ac-
cessed on 28 May 2021)) to further characterize and categorize proteins identified in our 
samples. To date, MatrisomeDB is the most complete database of ECM proteomic data 
and matrisomal proteins are divided into the “core matrisome” (i.e., glycoproteins, colla-
gens, and proteoglycans) and the “matrisome-associated proteins” (i.e., ECM-affiliated 
proteins, ECM regulators, and secreted factors) [35]. 
4.5. ECM Component Evaluation by Immunofluorescence 
Three adult and three old mice were deeply anesthetized with Tribromoethanol and 
sacrificed by cervical dislocation. Gastrocnemius muscles were quickly removed and fro-
zen in liquid nitrogen-precooled isopentane. Transversally sectioned 7-μm thick cryosec-
tions were incubated with 1% bovine serum albumin, 2% normal goat serum, 0.3% Triton® 
X-100 in phosphate buffer solution (PBS) for 1 h and immunolabelled with the following 
probes: a rabbit polyclonal antibody direct against type I collagen, diluted 1:50 (GeneTex, 
Irvine, CA, USA); a human monoclonal antibody direct against type VI collagen, diluted 
1:1000 (ICN Biomedicals, Costa Mesa, CA, USA); rabbit polyclonal antibody direct against 
laminin, diluted 1:800 (Abcam, Cambridge, UK), in double labeling with anti-collagen 
type VI. 
After washing with PBS, cryosections were stained with the proper secondary anti-
body: Alexafluor 488-anti-mouse antibodies diluted 1:200 for type VI collagen (Molecular 
Probes, Invitrogen, CA, USA). Alexafluor 594-anti-rabbit diluted 1:200, for laminin and 
collagen type I. The cryosections were finally counterstained for DNA with 0.1 μg/mL 
Hoechst 33258 and mounted in PBS:glycerol (1:1). 
An Olympus BX51 microscope equipped with a 100W mercury lamp (Olympus Ita-
lia, Milan, Italy) was used under the following conditions: 450–480 nm excitation filter 
(excf), 500 nm dichroic mirror (dm) for Alexa 488; 540 nm excf, 580 nm dm, and 620 nm 
barrier filter (bf) for Alexa 594; 330–385 nm excf, 400 nm dm, and 420 nm bf, for Hoechst 
33342. Images were recorded with an Olympus Magnifire digital camera system (Olym-
pus Italia). 
A routine was written in MATLAB (2018b version, Mathworks) to quantify the area 
covered by fluorescence-positive pixels for the total area in four random images acquired 
at X20 for each animal. 
4.6. Ultrastructural Morphological and Morphometrical Evaluation 
Three adult and three old mice were deeply anesthetized with Tribromoethanol drug 
and then perfused via the ascending aorta with 0.1 M PBS followed by 4% paraformalde-
hyde in PBS. The gastrocnemius muscle was quickly removed, and samples (about 1 mm3) 
were further placed for 2 h at 4 °C in 2.5% glutaraldehyde (Electron Microscopy Sciences, 
Hatfield, PA, USA) plus 2% paraformaldehyde in 0.1 M PBS. The samples were then 
rinsed with PBS, postfixed with 1% OsO4 (Electron Microscopy Sciences) and 1.5% potas-
sium ferrocyanide for 2 h at 4 °C, dehydrated with acetone, and embedded in Epon 812 
resin (Electron Microscopy Sciences). 
Ultrathin sections (70–90 nm thick) were stained with lead citrate for 1 min and ob-
served in a Philips Morgagni transmission electron microscope operating at 80 kV and 
equipped with a Megaview III camera for digital image acquisition. 
The morphometric evaluation of the endomysium thickness was performed on 20 
randomly selected electron micrographs (×5600) of longitudinally sectioned muscle, meas-
uring the distance between the sarcolemma of two adjacent muscle cells every 1 µm of 
sarcolemma length, for a total of 50 measurements per animal. 
For morphometric evaluation of the thickness of the basement membrane, a total of 
30 measurements per animal were performed. The thickness of the electrodense sheath 
covering the myofiber was considered on randomly selected electron micrographs 
(×36,000) of longitudinally sectioned muscles. 
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The morphometric evaluation of the perimysium collagen bundle size was per-
formed on a total of 10 longitudinally sectioned collagen bundles per animal. The index 
of collagen bundle linearity (X/Y, expressed as the ratio between the real length of the 
bundle profile and the corresponding linear length) was assessed on a total of 30 longitu-
dinally sectioned collagen bundles per age group. 
For morphometric evaluation of collagen fibrils, measurement of fibril size, as well 
as the distance between single collagen fibrils, was performed on a total of 100 longitudi-
nally sectioned collagen fibrils per age group. 
All measurements were made by using the Radius software for image acquisition 
and elaboration implemented in the Philips Morgagni transmission electron microscope. 
4.7. Statistical Analysis 
Statistical analysis of proteomic data was performed using Skyline group comparison 
tool, set as follows: normalization of runs was performed using “Equilize Medians” with 
0.95 as the confidence level; Tukey’s Median Polish was set as the summary method. The 
comparison was set comparing the value obtained in old skeletal muscle against those of 
adult samples. Proteins with a fold change > 1.5 or < 0.66 and a p value < 0.05 were signif-
icantly up-and down-regulated, respectively. 
Data on the percentage of fluorescent (positive) areas for laminin, collagen type VI, 
and type I and data of morphometrical evaluation of transmission electron microscopy 
images for endomysium size, basement membrane thickness, collagen bundle size and 
linearity, collagen fibril size, and distance were pooled according to the age group and 
presented as mean ± SEM. The Shapiro–Wilk test showed that data were not normally 
distributed (p < 0.001). Consequently, the subsequent statistical analysis was performed 
using the non-parametric Mann–Whitney test, setting statistical significance at p value ≤ 
0.05. The IBM-SPSS (v.25, Armonk, NY, USA) statistical package was used for all analyses. 
5. Conclusions 
This study provided the first characterization of the matrisome in the aging gas-
trocnemius muscle and highlights the higher age-dependent abundance of several identi-
fied ECM components (Figure 6). 
 
Figure 6. Schematic representation of matrix-sarcolemma axis of skeletal muscle fibre. Proteins differentially expressed 
between old and adult SM are reported in bold. ANGL7, angiopoietin-related protein 7; ANX, annexin; ASPN, asporin; 
CO, collagen; CATD, cathepsin D; DERM, dermatopontin; FINC, fibronectin; GPC1, Glypican 1; LAMA, laminin; LEG1, 
galectin 1; LUM, lumican; MMP, matrix metalloproteinase; MIME, mimecan; NID, nidogen; PEDF, pigment epithelium-
derived factor; PGS1, biglycan; POSTN, periostin; S10AA, protein S100-A10. 
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Since interactions between ECM molecules and between ECM and sarcolemma pro-
vide not only structural support but also a mechano-sensing transduction system and a 
source of cytokines and growth factors, the deepen insight on the matrisome in the aged 
SM can pave the way for a better understanding of the synergic interplay of the whole 
extracellular environment and of the mechanisms that can contribute to the age-depend-
ent muscle dysfunction by hindering, for instance, fiber contractility [91], lateral force 
transmission [92,93], tissue stiffness [49,50], and satellite cell function [12] through ECM-
driven signaling pathways. 
Supplementary Materials: The following are available online at www.mdpi.com/arti-
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